Circio Holding ASA Logo

Circio Holding ASA

Clinical-stage company developing circular RNA medicines and immunotherapies.

CRNA | OL

Overview

Corporate Details

ISIN(s):
NO0012858564 (+5 more)
LEI:
5967007LIEEXZXFYNS31
Country:
Norway
Address:
Vollsveien 19, 1366 Lysaker

Description

Circio Holding ASA is a clinical-stage company developing novel medicines based on circular RNA (circRNA) and immunotherapy. The company's core focus is its proprietary circVec platform, a circular RNA expression system designed to enhance the efficacy and durability of gene and cell therapies. Circio's development pipeline is directed towards immuno-oncology, targeting difficult-to-treat solid tumors, and the application of its circRNA technology to address genetic diseases.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-23 09:11
Correction: Circio Holding ASA Updated information to the notice of extraordi…
Norwegian 527.3 KB
2025-12-23 09:11
Correction: Circio Holding ASA Updated information to the notice of extraordi…
Norwegian 529.3 KB
2025-12-23 09:11
Correction: Circio Holding ASA Updated information to the notice of extraordi…
English 1.3 KB
2025-12-23 09:02
Circio Holding ASA Updated information to the notice of extraordinary general…
Norwegian 527.3 KB
2025-12-23 09:02
Circio Holding ASA Updated information to the notice of extraordinary general…
Norwegian 529.3 KB
2025-12-23 09:02
Circio Holding ASA Updated information to the notice of extraordinary general…
English 1.2 KB
2025-12-19 14:24
Circio Holding ASA Notice of extraordinary general meeting on 12 January 2026…
Norwegian 677.7 KB
2025-12-19 14:24
Circio Holding ASA Notice of extraordinary general meeting on 12 January 2026
English 5.5 KB
2025-12-08 10:00
Circio Holding ASA Key information related to the rights issue
English 9.3 KB
2025-12-08 07:00
Circio announces 88% underwritten and presubscribed NOK 50 million rights issue…
English 18.4 KB
2025-12-03 15:23
Corr*: Atlas Holdings for CIRCIO
English 854 bytes
2025-12-03 12:36
Atlas Holdings for CIRCIO
English 840 bytes
2025-11-25 15:22
Atlas Holdings for CIRCIO
English 815 bytes
2025-11-24 07:00
Circio presents data that further strengthens and broadens its circVec circular…
English 4.3 MB
2025-11-24 07:00
Circio presents data that further strengthens and broadens its circVec circular…
English 7.9 KB

Automate Your Workflow. Get a real-time feed of all Circio Holding ASA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Circio Holding ASA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Circio Holding ASA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.